Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 10Lymphoma 9Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, B-Cell 4Lymphoma, Non-Hodgkin 3Waldenstrom Macroglobulinemia 2Recurrence 2Lymphoma, T-Cell, Peripheral 2Hodgkin Disease 2Proteostasis Deficiencies 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Immunoglobulin Light-chain Amyloidosis 1Immunoblastic Lymphadenopathy 1Hematopoietic and Lymphoid System Neoplasm 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Central Nervous System Neoplasms 1Advanced Solid Tumor 1

Interventions

Standard of Care 3Practice Guidelines as Topic 3Interviews as Topic 2fludarabine 1Whole-Body Irradiation 1Watchful Waiting 1Telemedicine 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Palliative Care 1Observation 1Mycophenolic Acid 1Methods 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Filgrastim 1Educational Status 1Early Intervention, Educational 1Cyclophosphamide 1Counseling 1CT-P10 1Bendamustine Hydrochloride 1Behavior Therapy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hematopoietic and Lymphoid System Neoplasm × Bendamustine Hydrochloride × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡